Krebs Biochemicals and Industries Limited — Board Meeting, 09-02-2026: Outcome of Board Meeting

Krebs Biochemicals has approved its Q3FY26 financial results. The company posted revenue of ₹7.27 Cr and a loss of ₹3.13 Cr for the quarter. For the nine-month period, revenue was ₹16.92 Cr with a loss of ₹14.59 Cr. Its Vizag manufacturing unit remains closed since Feb 2025 due to regulatory orders.